Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our reports dated March 1, 2022, with respect to the consolidated financial statements of Xenon Pharmaceuticals Inc. and the effectiveness of internal control over financial reporting as of December 31, 2021, incorporated herein by reference.
/s/ KPMG LLP
Chartered Professional Accountants
Vancouver, Canada
June 2, 2022
